Skip to main content
Top
Published in: International Urology and Nephrology 1/2008

01-03-2008 | Editorial

The International Urology and Nephrology journal looks to the future

Author: Dimitrios G. Oreopoulos

Published in: International Urology and Nephrology | Issue 1/2008

Login to get access

Excerpt

A previous editorial indicated that, in order to improve our impact, we will no longer publish case reports, letters or editorials but we will accept only original articles and major in-depth reviews. Since then many of our readers have told us that they want to share information through case reports and also that they wish to comment on recent publications via letters to the editor [1, 2]. …
Literature
2.
go back to reference Oreopoulos DG (2006) International Urology and Nephrology enters a new era with high expectations. Int Urol Nephrol 38:403–405CrossRef Oreopoulos DG (2006) International Urology and Nephrology enters a new era with high expectations. Int Urol Nephrol 38:403–405CrossRef
Metadata
Title
The International Urology and Nephrology journal looks to the future
Author
Dimitrios G. Oreopoulos
Publication date
01-03-2008
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2008
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-008-9336-9

Other articles of this Issue 1/2008

International Urology and Nephrology 1/2008 Go to the issue

Commentary

Reply

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine